Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Rusconi

Showing results (41-50 of 192) with videos related to

Pageof 20
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West AfricaGianguglielmo Zehender, Erika Ebranati, Chiara De Maddalena, et al.
Open Forum Infectious Diseases|July 30, 2021
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical PracticeAlberto Borghetti, Andrea Giacomelli, Vanni Borghi, et al.
HIV Clinical Trials|June 21, 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugsPaolo Maggi, Vincenzo Montinaro, Stefano Rusconi, et al.
European Journal of Internal Medicine|October 23, 2019
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunitiesLorena van den Bogaart, Alice Ranzani, Letizia Oreni, et al.
AIDS Reviews|October 10, 2015
State of the Art of Dual Therapy in 2015Silvia Nozza, Valentina Svicher, Annalisa Saracino, et al.
AIDS (London, England)|January 25, 2003
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patientsPaola Costa, Stefano Rusconi, Manuela Fogli, et al.
BMC Infectious Diseases|June 23, 2021
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort studyAndrea Giacomelli, Federico Conti, Laura Pezzati, et al.
BMC Infectious Diseases|August 11, 2017
Cardiovascular risk and dyslipidemia among persons living with HIV: a reviewPaolo Maggi, Antonio Di Biagio, Stefano Rusconi, et al.
The New Microbiologica|May 2, 2025
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium speciesFrancesco Bassani, Gabriele Pagani, Marco Franzetti, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Pageof 20

Showing results (41-50 of 192) with videos related to

Sort By:
Pageof 20
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2008
Description of a "trans-Saharan" strain of human T-lymphotropic virus type 1 in West AfricaGianguglielmo Zehender, Erika Ebranati, Chiara De Maddalena, et al.
Open Forum Infectious Diseases|July 30, 2021
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical PracticeAlberto Borghetti, Andrea Giacomelli, Vanni Borghi, et al.
HIV Clinical Trials|June 21, 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugsPaolo Maggi, Vincenzo Montinaro, Stefano Rusconi, et al.
European Journal of Internal Medicine|October 23, 2019
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunitiesLorena van den Bogaart, Alice Ranzani, Letizia Oreni, et al.
AIDS Reviews|October 10, 2015
State of the Art of Dual Therapy in 2015Silvia Nozza, Valentina Svicher, Annalisa Saracino, et al.
AIDS (London, England)|January 25, 2003
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patientsPaola Costa, Stefano Rusconi, Manuela Fogli, et al.
BMC Infectious Diseases|June 23, 2021
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort studyAndrea Giacomelli, Federico Conti, Laura Pezzati, et al.
BMC Infectious Diseases|August 11, 2017
Cardiovascular risk and dyslipidemia among persons living with HIV: a reviewPaolo Maggi, Antonio Di Biagio, Stefano Rusconi, et al.
The New Microbiologica|May 2, 2025
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium speciesFrancesco Bassani, Gabriele Pagani, Marco Franzetti, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Pageof 20